Hep B, C Could Be Eliminated As Public Health Threats by 2030
Tools exist to prevent hepatitis B and C mortality, including vaccination and treatment
Extreme Preemies Benefit Most From Corticosteroids Before Birth
Effect size of corticosteroid exposure on mortality greater at lowest gestations
Apixaban Tx Cost in A-Fib Meets U.S. Norms for Reasonable Value
Incremental cost of achieving longer life expectancy within accepted U.S. norm ($53,925/QALY)
DAPT Cessation Patterns Vary With Diabetes Status After PCI
Risk of major adverse cardiovascular events up for DAPT disruption, regardless of diabetes status
Substance Abuse Is a Treatable Chronic Medical Condition
ACP position paper outlines health and public policy interventions for effective prevention and treatment
FDA Approves Dupixent to Treat Eczema
Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation
Inadvertent HPV Vax Doesn’t Up Risk of Poor Pregnancy Outcomes
No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA
FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis
First drug sanctioned in United States for primary progressive multiple sclerosis
FDA Approves Zejula for Certain Female Cancers
PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum
Teens Exposed to Opioid Rx at Risk for Serious Outcomes
Teens more likely than younger children to have health facility admission, serious medical outcome
